Novavax CEO discusses earnings, COVID-19 vaccine trial progress, and FDA approval
Novavax CEO discusses earnings, COVID-19 vaccine trial progress, and FDA approval

Yahoo Finance’s Anjalee Khemlani spoke to Novavax CEO Stanley Erck about the Novavax earnings, vaccine trial, and FDA approval.